Date Announced: 19 Nov 2014
Chief medical offer departs as dental laser firm undergoes more reshaping.
IRVINE, CA (November 19, 2014) - BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today reported that Alexander K. Arrow, M.D. has resigned as Chief Medical Officer and will be leaving the Company effective December 3, 2014 to pursue other opportunities.
Jeffrey M. Nugent, President and Chief Executive Officer, stated, "Alex is a consummate team player who has changed roles several times at BIOLASE -- each time in response to what needed to be done. While at the Company, Alex stood up for what was best for BIOLASE, its customers, and its shareholders while it was undergoing a Board transition this spring. We appreciate his untiring efforts during his tenure and we wish him the best in the next phase of his career."
Dr. Arrow joined the BIOLASE Board of Directors in July 2010. He remained on the Board and served as chairman of the Audit and Compensation committees until June 2013. In June 2013, he was named President and Chief Operating Officer and he served in that role until he was appointed Chief Medical Officer in September of this year.
Dr. Arrow commented, "I'm pleased to have played a role in the reshaping of the Company and to have helped develop its new strategy. Now it is time to execute that strategy under the leadership of President and Chief Executive Officer Jeff Nugent. I'm also proud that the people I recruited to BIOLASE are in senior leadership positions that make use of their talents. I wish the Company well and appreciate having had the opportunity to serve its stakeholders."
E-mail: via web site
Web Site: www.biolase.com